Deng Y, Wu Q, Zhang W, Jiang H, Xu C, Chen S
J Transl Med. 2025; 23(1):328.
PMID: 40087679
DOI: 10.1186/s12967-025-06350-4.
Yang J, Yamashita-Kanemaru Y, Morris B, Contursi A, Trajkovski D, Xu J
Nature. 2025; .
PMID: 40044852
DOI: 10.1038/s41586-025-08626-7.
Okamoto K, Kanou T, Kawagishi S, Nagata H, Morii E, Shintani Y
Gen Thorac Cardiovasc Surg Cases. 2025; 4(1):9.
PMID: 40011974
PMC: 11863716.
DOI: 10.1186/s44215-025-00190-w.
Chen S, Zhang X, Basappa B, Zhu T, Pandey V, Lobie P
Commun Med (Lond). 2025; 5(1):45.
PMID: 39984660
PMC: 11845601.
DOI: 10.1038/s43856-024-00710-9.
Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X
Signal Transduct Target Ther. 2025; 10(1):57.
PMID: 39979279
PMC: 11842613.
DOI: 10.1038/s41392-025-02148-4.
Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies.
Yang S, Seo J, Choi J, Kim S, Kuk Y, Park K
Mol Cancer. 2025; 24(1):47.
PMID: 39953555
PMC: 11829473.
DOI: 10.1186/s12943-025-02250-9.
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.
Tufail M, Jiang C, Li N
Mil Med Res. 2025; 12(1):7.
PMID: 39934876
PMC: 11812268.
DOI: 10.1186/s40779-025-00595-2.
Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche.
Mondal J, Zhang J, Qing F, Li S, Kumar D, Huse J
Nat Commun. 2025; 16(1):1378.
PMID: 39910049
PMC: 11799300.
DOI: 10.1038/s41467-025-56347-2.
Advances in adjuvant therapy for operable N2 non-small cell lung cancer: a narrative review.
Liu L, Mao Y, Guo L, Li C, Wang Y
Front Oncol. 2025; 14:1523743.
PMID: 39906659
PMC: 11790610.
DOI: 10.3389/fonc.2024.1523743.
Autophagy induced by metabolic processes leads to solid tumor cell metastatic dormancy and recurrence.
Ferdousmakan S, Mansourian D, Seyedi Asl F, Fathi Z, Maleki-Sheikhabadi F, Nabi Afjadi M
Med Oncol. 2025; 42(3):62.
PMID: 39899220
DOI: 10.1007/s12032-025-02607-6.
Macro- and micro-nutrient-based multiplex stress conditions modulate in vitro tumorigenesis and aggressive behavior of breast cancer spheroids.
Gayan S, Teli A, Nair A, Tomar G, Dey T
In Vitro Model. 2025; 1(1):85-101.
PMID: 39872971
PMC: 11756478.
DOI: 10.1007/s44164-021-00006-5.
SOX2 control activation of dormant prostate cancer cells in bone metastases by promoting CCNE2 gene expression.
Deng M, Huang P, Huang Z, Chen T, Luo X, Liao C
Am J Clin Exp Urol. 2025; 12(6):375-388.
PMID: 39839747
PMC: 11744349.
DOI: 10.62347/ASCY2532.
Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer Management: Opportunities and Challenges.
Ye Y, Yu S, Guo T, Zhang S, Shen X, Han G
Biomolecules. 2025; 14(12.
PMID: 39766230
PMC: 11673737.
DOI: 10.3390/biom14121523.
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer.
Gu Y, Yang R, Zhang Y, Guo M, Takehiro K, Zhan M
Mol Biomed. 2025; 6(1):2.
PMID: 39757310
PMC: 11700966.
DOI: 10.1186/s43556-024-00239-2.
Stemness regulation in prostate cancer: prostate cancer stem cells and targeted therapy.
Liang H, Zhou B, Li P, Zhang X, Zhang S, Zhang Y
Ann Med. 2024; 57(1):2442067.
PMID: 39711287
PMC: 11703425.
DOI: 10.1080/07853890.2024.2442067.
The metastatic cascade through the lens of therapeutic inhibition.
Miranda I, Jahan N, Shevde L
Cell Rep Med. 2024; 6(1):101872.
PMID: 39706193
PMC: 11866422.
DOI: 10.1016/j.xcrm.2024.101872.
Exosome-delivered NR2F1-AS1 and NR2F1 drive phenotypic transition from dormancy to proliferation in treatment-resistant prostate cancer via stabilizing hormonal receptors.
Chen W, Mao Y, Zhan Y, Li W, Wu J, Mao X
J Nanobiotechnology. 2024; 22(1):761.
PMID: 39695778
PMC: 11657369.
DOI: 10.1186/s12951-024-03025-y.
Cancer Cells in Sleep Mode: Wake Them to Eliminate or Keep Them Asleep Forever?.
Liu W, Kovacs A, Hou J
Cells. 2024; 13(23).
PMID: 39682769
PMC: 11640528.
DOI: 10.3390/cells13232022.
Molecular mechanism of bone metastasis in breast cancer.
Sui L, Wang J, Jiang W, Song X, Ye L
Front Oncol. 2024; 14:1401113.
PMID: 39605887
PMC: 11599183.
DOI: 10.3389/fonc.2024.1401113.
Tracing Quiescent Cancer Cells In Vivo.
Kim M
Cancers (Basel). 2024; 16(22).
PMID: 39594777
PMC: 11593267.
DOI: 10.3390/cancers16223822.